A world away from venture capital funds: biotechnology and finance in Shanghai
by Brian Richard, Ken Malone, Brent D. Hales, Markus A. Turkopuls
International Journal of Technoentrepreneurship (IJTE), Vol. 2, No. 1, 2009

Abstract: A survey of the financing methods of 19 Shanghai medicinal biotechnology companies revealed a lack of private venture capital fund participation. Alternatively, these companies have obtained financing from government sources based substantially on the reputation and relationships of the companies' officers with government officials. This aligns with recent literature suggesting that China is an exception to the dominant body of literature on the relationship of strong legal and financial institutions to the commercialisation process. The dominant body of literature suggests that strong legal and financial institutions are needed to provide patent protection to promote inventions and their commercialisation which, in turn, protects investors and promotes financing of the commercialisation process.

Online publication date: Fri, 31-Jul-2009

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technoentrepreneurship (IJTE):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com